SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,336.45 332.63
( 0.45%)

Global Indices

Nasdaq

52,102.03 -340.17
(-0.65%)

Dow Jones

7,605.54 -35.44
(-0.46%)

Hang Seng

63,783.20 299.10
(0.47%)

Nikkei 225

10,654.59 -42.98
(-0.40%)

Forex

USD-INR

95.28 -0.19
(-0.20%)

EUR-INR

110.09 -0.64
(-0.57%)

GBP-INR

128.59 -0.52
(-0.40%)

JPY-INR

0.62 0.00
(-0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Dishman Carbogen Amcis Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540701

INE385W01011

247.6176796

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DCAL

2553.21

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	231.56	399.84	327.35	402.55	306.61	200.32
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	231.56	399.84	327.35	402.55	306.61	200.32
Other Income	84.52	32.98	63.05	52.16	60.39	66.15
Stock Adjustments	16.36	-14.00	-8.27	-8.00	7.70	-22.54
Total Income	332.44	418.82	382.13	446.71	374.70	243.93
EXPENDITURE :
Raw Materials	55.67	117.01	107.70	163.35	107.11	75.04
Power & Fuel Cost	23.87	32.16	28.71	33.07	24.83	12.78
Employee Cost	86.63	90.15	91.54	86.13	79.04	58.23
Other Manufacturing Expenses	20.96	21.69	27.94	31.21	22.57	18.95
Selling & Administrative Expenses	52.50	50.59	46.30	52.54	46.03	28.90
Miscellaneous Expenses	2.97	2.45	13.14	22.49	2.21	43.20
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	242.60	314.05	315.33	388.79	281.79	237.10
Operating Profit	89.84	104.77	66.80	57.92	92.91	6.83
Interest	86.52	70.40	68.19	57.92	37.23	34.17
Gross Profit	3.32	34.37	-1.39	0.00	55.68	-27.34
Depreciation	62.57	65.20	101.61	96.20	140.07	141.35
Profit Before Tax	-59.25	-30.83	-103.00	-96.20	-84.39	-168.69
Tax	0.00	0.00	11.06	0.00	0.00	17.97
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-20.85	-20.96	-37.65	-37.33	-52.84	46.15
Reported Net Profit	-38.40	-9.87	-76.41	-58.87	-31.55	-232.81
Extraordinary Items	1.13	1.31	-1.02	-2.79	-0.79	2.52
Adjusted Net Profit	-39.53	-11.18	-75.39	-56.08	-30.76	-235.33
Adjustment below Net Profit	0.00	0.49	-0.07	0.33	0.10	-0.51
P & L Balance brought forward	-320.31	-310.93	-234.45	-175.91	-144.47	88.85
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-358.71	-320.31	-310.93	-234.45	-175.92	-144.47
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-2.45	-0.63	-4.87	-3.75	-2.01	-14.85
Earnings Per Share(Adj)-Unit Curr	-2.45	-0.63	-4.87	-3.75	-2.01	-14.85
Book Value-Unit Curr	247.59	257.05	258.46	262.39	269.88	298.13
Book Value(Adj)-Unit Curr	247.59	257.05	258.46	262.39	269.88	298.13

74,336.45 332.63 ( 0.45%)

52,102.03 -340.17 (-0.65%)

7,605.54 -35.44 (-0.46%)

63,783.20 299.10 (0.47%)

10,654.59 -42.98 (-0.40%)

95.28 -0.19 (-0.20%)

110.09 -0.64 (-0.57%)

128.59 -0.52 (-0.40%)

0.62 0.00 (-0.70%)